Heat Shock Protein HSP10: Potential Drug Target Or Biomarker (G4956)

Target Name: ODF1

NCBI ID: G4956

ODF1

Heat Shock Protein HSP10: Potential Drug Target Or Biomarker

Heat shock protein (HSP) beta-10 (HSP尾10) is a protein that is expressed in a variety of cell types and is involved in the regulation of protein folding and localization. HSP尾10 is also known as ODF1 (Oxidative stress-induced factor 1), and research has suggested that it may have potential as a drug target or biomarker.

The protein encoded by the HSP尾10 gene is a 14kDa protein that is expressed in a variety of tissues and cells. It is highly conserved across different species, and has been shown to be involved in the regulation of protein folding and localization. HSP尾10 is a heat shock-induced protein, which means that it is expressed in high levels in the cells under stress due to temperature or other environmental factors.

One of the key functions of HSP尾10 is its ability to interact with other proteins and molecules, including other heat shock proteins and transcription factors. HSP尾10 has been shown to play a role in the regulation of protein folding and localization, and has been shown to interact with a variety of protein partners.

In addition to its role in protein folding and localization, HSP尾10 has also been shown to be involved in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. HSP尾10 has been shown to play a role in the regulation of cell growth by inhibiting the activity of the oncogene bad1 (BAP1), which promotes cell growth and is often associated with cancer.

HSP尾10 has also been shown to be involved in the regulation of apoptosis, which is the process by which cells die when they are no longer needed. HSP尾10 has been shown to play a role in the regulation of apoptosis by interacting with the protein Bax and promoting the production of pro-apoptotic proteins.

In addition to its role in apoptosis, HSP尾10 has also been shown to be involved in the regulation of inflammation. HSP尾10 has been shown to play a role in the regulation of inflammation by interacting with the protein NF-kappa-B and promoting the production of pro-inflammatory proteins.

The potential implications of HSP尾10 as a drug target or biomarker are significant. HSP尾10 has been shown to play a role in the regulation of a variety of cellular processes, including protein folding and localization, cell growth, apoptosis, and inflammation. As such, HSP尾10 may be a promising target for drugs that are designed to modulate these processes.

For example, HSP尾10 has been shown to play a role in the regulation of protein folding and localization, which may make it a potential target for drugs that are designed to modulate protein function. Additionally, HSP尾10 has been shown to play a role in the regulation of cell growth, apoptosis, and inflammation, which may make it a potential target for drugs that are designed to modulate these processes.

In conclusion, HSP尾10 is a protein that is expressed in a variety of cell types and is involved in the regulation of protein folding and localization, cell growth, apoptosis, and inflammation. As such, HSP尾10 may be a promising target for drugs that are designed to modulate these processes. Further research is needed to fully understand the potential implications of HSP尾10 as a drug target or biomarker.

Protein Name: Outer Dense Fiber Of Sperm Tails 1

Functions: Component of the outer dense fibers (ODF) of spermatozoa. ODF are filamentous structures located on the outside of the axoneme in the midpiece and principal piece of the mammalian sperm tail and may help to maintain the passive elastic structures and elastic recoil of the sperm tail

The "ODF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ODF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets